Featured Clinical Research
Jump to …
UT Southwestern investigators are recruiting patients with recent kidney stone passage or surgery for a research study to determine if behavioral interventions (based on the use of a “smart water bottle”) can increase fluid intake and help prevent having another kidney stone. If you are interested in participating and would like more information, please contact Cynthia Rangel at email@example.com or 214-645-8787.
Volunteers are needed for an MRI research study. This study involves the development and evaluation of new MRI software sequences and coils. You may be able to participate if you are between 18 and 89 years of age. You cannot participate if you have any contraindications to MRI, which include pacemakers, internal cardiac defibrillators, ferro-magnetic implants, a history of metal fragments in your body, and claustrophobia. Eligible participants will be compensated for their time. If you are interested in participating and would like more information, please contact Kelli Key at MRI@UTSouthwestern.edu or 214-645-1568.
UT Southwestern Medical Center researchers are seeking individuals with a lifetime or current diagnosis of a mood disorder, including depression, for an observational study looking for biomarkers of depression. Eligible participants must be 10 years old or older and will complete assessments, MRI, EEG, biospecimen collection, and neurocognitive testing. Compensation is provided for completing components of the study. For more information, please contact Dr. Madhukar Trivedi’s team at the Center for Depression Research and Clinical Care at 214-648-4357 or D2K@utsouthwestern.edu.
Are you or someone you know concerned that you may have systemic lupus erythematosus (lupus)? The Division of Rheumatic Diseases at UT Southwestern Medical Center is conducting a study to assess individuals with incomplete lupus. Eligible participants must be between 15 and 45 years of age, have a positive ANA, and have not been diagnosed with lupus. Eligible participants will be invited to enter the treatment phase of the study of an FDA-approved medication for lupus, which lasts for 24 months. Medications and blood testing are at no cost. For more information, call Azza Badr at 214-648-8978 or email at firstname.lastname@example.org.